Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Anti–PD-L1 Monoclonal Antibody MPDL3280A in Metastatic Urothelial Bladder Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Long-Term Follow-Up Results of MPDL3280A in Metastatic Renal-Cell Carcinoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Dose-Ranging Phase 2 Results of Nivolumab Therapy in Metastatic Renal-Cell Carcinoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Pembrolizumab in the Treatment of Patients with Advanced Urothelial Tract Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read More
Interim Analysis of BATON-CRC: Tivozanib plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer
ESMO 2014 - Gastrointestinal and Head & Neck Cancer
,
ESMO
Conference Correspondent
Read More
Updated STRIDE and STAND Trial Results: Optimal Sipuleucel-T Use in Metastatic Prostate Cancer
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
Read More
Androgen Receptor and CYP17A1 Copy Number Variations as Predictors of Outcomes in Patients with Metastatic Prostate Cancer Receiving Abiraterone
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
Read More
Adding Docetaxel to ADT Significantly Improves Survival versus ADT Alone in Patients with High-Volume Metastatic Prostate Cancer
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
Read More
Early PSA Response as a Prognostic Factor in Metastatic Prostate Cancer
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
Read More
Emerging Agents for Metastatic Prostate Cancer: Galeterone, Selinexor, and ARN-509
ESMO 2014 - Prostate Cancer
,
ESMO
Conference Correspondent
Read More
Page 215 of 329
212
213
214
215
216
217
218
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
From Chaos to Clarity: Data-Driven Denial Prevention
Shawntea (Taya) Gordon, MBA, FACMPE
3.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma